JB

James E. Bradner

AP Acetylon Pharmaceuticals: 4 patents #7 of 29Top 25%
HI Howard Hughes Medical Institute: 1 patents #66 of 128Top 55%
BU Boston University: 1 patents #420 of 1,102Top 40%
WR Whitehead Institute For Biomedical Research: 1 patents #217 of 438Top 50%
Overall (All Time): #106,650 of 4,157,543Top 3%
33
Patents All Time

Issued Patents All Time

Showing 25 most recent of 33 patents

Patent #TitleCo-InventorsDate
12023385 Tunable endogenous protein degradation with heterobifunctional compounds Dennis Buckley, Georg Winter, Andrew J. Phillips, Timothy Heffernan, Justin Roberts +1 more 2024-07-02
11617750 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof John H. van Duzer, Ralph Mazitschek, Walter Ogier, Guoxiang Huang, Dejian Xie +1 more 2023-04-04
11583586 Methods to induce targeted protein degradation through bifunctional molecules Dennis Buckley, Georg Winter 2023-02-21
11311609 Regulating chimeric antigen receptors Justin Roberts, Behnam Nabet, Georg Winter, Andrew J. Phillips, Timothy Heffernan +1 more 2022-04-26
11293023 Tunable endogenous protein degradation Dennis Buckley, Georg Winter, Andrew J. Phillips, Timothy Heffernan, Justin Roberts +1 more 2022-04-05
11285218 Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use Dennis Buckley, David Ian Remillard 2022-03-29
11059801 Methods to induce targeted protein degradation through bifunctional molecules Dennis Buckley, Georg Winter 2021-07-13
11046954 Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses Justin Roberts, Behnam Nabet, Georg Winter, Andrew J. Phillips, Timothy Heffernan +1 more 2021-06-29
10925868 Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use Nathanael S. Gray, Li Tan, Hai-Tsang Huang, Dennis Buckley, Georg Winter +1 more 2021-02-23
10899768 Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use Dennis Buckley, Mette Ishoey ROSENBAUM, Georg Winter 2021-01-26
10849980 Methods to induce targeted protein degradation through bifunctional molecules Dennis Buckley, Georg Winter 2020-12-01
10702504 Degradation of tripartite motif-containing protein 24 (TRIM24) by conjugation of TRIM24 inhibitors with E3 ligase ligand and methods of use Dennis Buckley, Lara Nicole Gechijian 2020-07-07
10172821 Histone deacetylase inhibitors Ralph Mazitschek 2019-01-08
10172905 Treatment of protein degradation disorders Kenneth C. Anderson, Edward Franklin Greenberg, Teru Hideshima, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more 2019-01-08
10087149 Selective histone deacetylase 8 inhibitors Aaron Beaty BEELER, John A. Porco, Jr., Oscar Ingham 2018-10-02
10071129 Method for identifying bromodomain inhibitors Richard A. Young, Peter B. Rahl 2018-09-11
10059657 Class-and isoform-specific HDAC inhibitors and uses thereof Ralph Mazitschek 2018-08-28
9724321 Histone deacetylase inhibitors Ralph Mazitschek 2017-08-08
9572854 Treatment of protein degradation disorders Kenneth C. Anderson, Edward Franklin Greenberg, Teru Hideshima, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more 2017-02-21
9567301 Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors Michael R. McKeown, Peter B. Rahl, Richard A. Young, Jason J. Marineau 2017-02-14
9540317 Class- and isoform-specific HDAC inhibitors and uses thereof Ralph Mazitschek 2017-01-10
9434686 Deacetylase inhibitors and uses thereof Weiping Tang, Stuart L. Schreiber 2016-09-06
9199923 Histone deacetylase inhibitors Ralph Mazitschek 2015-12-01
8999289 Treatment of protein degradation disorders Kenneth C. Anderson, Edward Franklin Greenberg, Teru Hideshima, Nicholas Paul Kwiatkowski, Ralph Mazitschek +3 more 2015-04-07
8754237 Bifunctional histone deacetylase inhibitors Ralph Mazitschek, Weiping Tang, Stuart L. Schreiber 2014-06-17